A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2019-10-21
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 237
- Registration Number
- NCT04133636
- Locations
- πΊπΈ
Cleveland Clinic, Cleveland, Ohio, United States
πΊπΈUniversity Of California San Diego, San Diego, California, United States
πΊπΈUniversity of California San Francisco, San Francisco, California, United States
A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma
- First Posted Date
- 2019-10-09
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 21
- Registration Number
- NCT04121260
- Locations
- π¨π³
Peking University Third Hospital, Beijing, China
π¨π³The Third Xiangya Hospital, Central South University, Changsha, China
π¨π³Nanfang Hospital, Guangzhou, China
A Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Administered as Tablets
- Conditions
- Healthy
- Interventions
- Drug: JNJ-64417184
- First Posted Date
- 2019-10-09
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04121052
- Locations
- π³π±
PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini, Groningen, Netherlands
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
- Conditions
- Warm Autoimmune Hemolytic Anemia
- Interventions
- Drug: M281Drug: Placebo
- First Posted Date
- 2019-10-08
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 111
- Registration Number
- NCT04119050
- Locations
- πΊπΈ
MemorialCare Medical Group, Fountain Valley, California, United States
πΊπΈUniversity of Southern California, Los Angeles, California, United States
πΊπΈCompassionate Cancer Care, Riverside, California, United States
A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Interventions
- First Posted Date
- 2019-10-02
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 17418
- Registration Number
- NCT04113551
- Locations
- πΊπΈ
Janssen Investigative Site, Titusville, New Jersey, United States
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
- Conditions
- Prostatic Neoplasms
- Interventions
- First Posted Date
- 2019-09-30
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 75
- Registration Number
- NCT04108208
- Locations
- π¨π³
Hunan Cancer hospital, Changsha, China
π¨π³Fujian Medical University Union Hospital, Fuzhou, China
π¨π³Zhejiang Cancer Hospital, Hang Zhou, China
A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2019-09-30
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 290
- Registration Number
- NCT04108195
- Locations
- π¨π¦
Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
πΊπΈCity of Hope National Medical Center, Duarte, California, United States
πΊπΈCity of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States
A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease
- Conditions
- Crohn Disease
- Interventions
- Drug: PlaceboDrug: JNJ-67864238
- First Posted Date
- 2019-09-25
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT04102111
- Locations
- π¦π·
Cer Instituto Medico, Buenos Aires, Argentina
π¦π·Sanatorio Duarte Quiroz, Cordoba, Argentina
π¦π·Centro de Investigaciones Medicas Mar Del Plata, Mar Del Plata, Argentina
A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy Participants
- Conditions
- Healthy
- Interventions
- Drug: JNJ-53718678Drug: JNJ-64417184
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 16
- Registration Number
- NCT04090086
- Locations
- π³π±
PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini, Groningen, Netherlands
A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult Participants
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 36
- Registration Number
- NCT04087759
- Locations
- π§πͺ
SGS Life Science Services, Antwerpen, Belgium